Actively Recruiting
Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss
Led by Meir Medical Center · Updated on 2025-05-06
60
Participants Needed
2
Research Sites
275 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Assessing the efficiency of Prophylactic use of local tranexamic acid during vaginal hysterectomy to reduce blood loss during operation
CONDITIONS
Official Title
Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients aged 20 to 90 years
- Undergoing vaginal hysterectomy
You will not qualify if you...
- Massive bleeding during operation caused by major vessel injury
- Known bleeding disorders (coagulopathies)
- Sensitivity or allergy to tranexamic acid
- Medical need for tranexamic acid during operation due to bleeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Meir Medical Center
Kfar Saba, Israel, Israel, 11125
Not Yet Recruiting
2
Meir medical center
Kfar Saba, Israel
Actively Recruiting
Research Team
Y
Yair Daykan, M.D
CONTACT
G
Gal Cohen, M.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here